CLSD - Clearside Biomedical, Inc.
0.41
-0.151 -36.902%
Share volume: 2,599,533
Last Updated: 11-28-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.56
-0.15
-0.27%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 05-15-2025 | 08-08-2025 | 11-14-2025 | |
| Total revenue | 230.000 K | 90.000 K | 1.038 M | 306.000 K | 2.330 M | 492.000 K | 201.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 149.000 K | 248.000 K | 0.000 | 0.000 | |
| Gross profit | 230.000 K | 90.000 K | 1.038 M | 157.000 K | 2.082 M | 492.000 K | 201.000 K | |
| -60.87% | 1,053.33% | -84.87% | 1,226.11% | -76.37% | -59.15% | |||
| Operating expenses | 8.439 M | 7.680 M | 6.972 M | 7.306 M | 7.287 M | 4.060 M | 7.241 M | |
| Selling general and admin | 2.824 M | 3.077 M | 2.844 M | 3.062 M | 2.824 M | 2.476 M | 4.308 M | |
| Research and development | 5.615 M | 4.603 M | 4.128 M | 4.244 M | 4.463 M | 1.584 M | 2.933 M | |
| Total expenses | 8.439 M | 7.680 M | 6.972 M | 7.306 M | 7.287 M | 4.060 M | 7.241 M | |
| -8.99% | -9.22% | 4.79% | -0.26% | -44.28% | 78.35% | |||
| Operating income | -8.209 M | -7.590 M | -5.934 M | -7.149 M | -5.205 M | -3.568 M | -7.040 M | |
| Ebit | -8.209 M | -7.591 M | -5.934 M | -7.149 M | -4.998 M | -1.848 M | -3.467 M | |
| Pretax income | -10.264 M | -9.512 M | -8.053 M | -9.370 M | -7.508 M | -4.495 M | -5.972 M | |
| -7.33% | -15.34% | 16.35% | -19.87% | -40.13% | 32.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 715.000 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.763 M | -7.594 M | -7.688 M | -7.307 M | -8.223 M | -4.495 M | -5.972 M | |
| 35.44% | -1.24% | 4.96% | -12.54% | 45.34% | -32.86% |